University of Colorado - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

University of Colorado - Pharmaceuticals & Healthcare - Deals and Alliances Profile

University of Colorado - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
University of Colorado - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
43 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

University of Colorado is an educational university that provides teaching and learning, research activity, and community services. The university offers a wide range of academic programs for undergraduate, graduate and professional study. Its academic programs comprise bachelor's programs, master's programs, doctoral programs, certificate programs, health programs, pre-collegiate, and features programs. University of Colorados undergraduate program of study comprise business and administration; letters, arts and sciences; engineering and applied science, school of public affairs, elementary education, and others.

University of Colorado - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major rece

  
Source:
Document ID
GDPH72684D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables41
  List of Figures51
University of Colorado, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201652
University of Colorado, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201671
University of Colorado, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201681
University of Colorado, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201691
University of Colorado, Medical Devices Deals, 2010 to YTD 2016101
University of Colorado, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016112
University of Colorado, Pharmaceuticals &Healthcare, Deal Details1326
  Venture Financing131
    UrgentRx Raises US$0.05 Million In Venture Financing131
  Partnerships141
    Nanoly Bioscience Enters Into Option For Licensing Agreement With University of Colorado For Nano-Polymer Technology141
    AmideBio Enters Into Licensing Agreement With University of Colorado For Peptide Manufacturing Technology151
    Illumina Enters into Agreement with University of Colorado at Denver161
    Sequenom Enters into Agreement with University of Colorado Denver171
    OXIS International Forms Joint Venture With University Of Colorado181
    miRagen Therapeutics Enters Research Collaboration With University of Colorado191
    University of Colorado Enters Into Research Agreement With Texas A&M Health201
  Licensing Agreements211
    Aeolus Pharma Enters into Licensing Agreement with University of Colorado211
    NantBioScience Enters into Licensing Agreement with University of Colorado221
    Ocugen Enters into Licensing Agreement with University of Colorado231
    SixOne Solutions Enters into Licensing Agreement with University of Colorado241
    Syndax Pharma Enters into Licensing Agreement with University of Colorado251
    Orphan Technologies Enters Into Licensing Agreement With University of Colorado To Develop Enzyme Replacement Therapy261
    Omni Bio Pharma Enters into Licensing Agreement with Regents of the University of Colorado271
    MediciNova Enters Into Licensing Agreement With University of Colorado Boulder For Ibudilast281
    Xeris Pharma Enters Into Licensing Agreement With University of Colorado291
    AmideBio Enters Into Licensing Agreement With University of Colorado For Alzheimer s Disease301
    Soligenix Enters Into Licensing Agreement With University Of Colorado312
    Arch Biopartners Enters Into Licensing Agreement With University Of Colorado331
    Colorado Cancer Therapeutics Exercises Its Option Licensing Agreement With University of Colorado And Emory University341
    ICVrx Enters Into Licensing Agreement With University of Colorado351
    Western States BioPharma Enters Into Licensing Agreement With University of Colorado361
    AmideBio Enters Into Licensing Agreement With University of Colorado371
  Asset Transactions381
    Amerita Acquires Chartwell Rocky Mountain381
University of Colorado - Key Competitors391
Key Employees401
Locations And Subsidiaries412
  Head Office411
  Other Locations &Subsidiaries412
Appendix431
  Methodology431
  About GlobalData431
  Contact Us431
  Disclaimer431

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "University of Colorado - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/University-of-Colorado-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-17180>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). University of Colorado - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/University-of-Colorado-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-17180>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research